Coupang Other Income (Expense) decreased by 63.0% to -$44.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 222.2%, from $36.00M to -$44.00M. Over 3 years (FY 2021 to FY 2024), Other Income (Expense) shows a downward trend with a 52.9% CAGR.
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
other_income_expense_net| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $373.00K | -$4.03M | -$3.43M | $490.00K | -$9.23M | $11.22M | -$9.20M | -$6.54M | -$5.24M | -$7.78M | $0.00 | -$9.00M | $12.00M | $4.00M | -$46.00M | $36.00M | $19.00M | -$27.00M | -$44.00M |
| QoQ Change | — | <-999% | +14.7% | +114.3% | <-999% | +221.6% | -182.0% | +28.9% | +19.9% | -48.4% | +100.0% | — | +233.3% | -66.7% | <-999% | +178.3% | -47.2% | -242.1% | -63.0% |
| YoY Change | — | — | — | — | <-999% | +378.8% | -167.9% | <-999% | +43.2% | -169.3% | +100.0% | -37.6% | +329.0% | +151.4% | — | +500.0% | +58.3% | -775.0% | -222.2% |